Literature DB >> 3429382

Influence of amoxycillin, erythromycin and roxithromycin on colonization resistance and on appearance of secondary colonization in healthy volunteers.

E J Vollaard1, H A Clasener, A J van Griethuysen, A J Janssen, A J Sanders-Reijmers.   

Abstract

We investigated the influence of oral administration of amoxycillin, erythromycin and roxithromycin on colonization resistance in healthy volunteers. Antibiotics were administered in a randomized cross-over design. No effect on the colonization resistance of the oropharynx could be demonstrated. Amoxycillin decreased the colonization resistance of the bowel against Enterobacteriaceae and yeasts, whose median concentration in faeces increased 100-fold and 30-fold respectively. Roxithromycin and erythromycin decreased the concentration of Enterobacteriaceae in faeces. Secondary colonization with Enterobacteriaceae was detected as often following roxithromycin as following amoxycillin, but the level of colonization with these bacteria was much higher following amoxycillin. Following roxithromycin and erythromycin the level of secondary colonization did not exceed the original concentration of Enterobacteriaceae, showing that these antibiotics did not decrease the colonization resistance against Enterobacteriaceae. The appearance of secondary colonization in faeces at levels equal to or lower than the concentration of Enterobacteriaceae before administration of antibiotics, should not be regarded as proof of disturbance of colonization resistance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429382     DOI: 10.1093/jac/20.suppl_b.131

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.

Authors:  H Lode; C Müller; K Borner; C E Nord; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Faecal level of urobilinogen: an indication for the risk of superinfection and of failure of oral anticonception?

Authors:  E J Vollaard; M M Jankowiak; N F Muller; H A Clasener
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

Review 3.  The intestinal microbiota and susceptibility to infection in immunocompromised patients.

Authors:  Ying Taur; Eric G Pamer
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

4.  Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit.

Authors:  C L de Champs; D P Guelon; R M Garnier; M C Poupart; O Y Mansoor; F L Dissait; J L Sirot
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.

Authors:  Eric G Pamer
Journal:  Science       Date:  2016-04-29       Impact factor: 47.728

Review 6.  Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  R A Young; J P Gonzalez; E M Sorkin
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.